Whenever there is "significant news" (and I would call claim of first revenue for an R&D company significant), one would normally expect some serious volume.

I wonder if it all sounds too good to be true, and new investors perhaps look at the stock/company history and assume this is all hype until either an external partner (eg: Inverness) makes a serious move or the board can honestly show some revenue.

Also, there is the catch 22 of trading over the counter to get started; though many investors are scared off by a senior exchange.

Other thoughts?

P.S. I have to admit that that presentation reminds of just how serious this could be. If it does in fact work as well as touted, Dr Burger has grossly understated the potential revenue stream.

For example, everyone with a genetic predisposition to cancer (like me), would begin taking this test at least annually for their entire adult life. This would be life changing in a number of ways.